FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,117 letters match. Newest first.

  1. Hi-Pro Feeds, LLC

    Hi-Pro Feeds made medicated goat feed linked to goat deaths; FDA cited missing urea hazard controls and late report.

    High risk
  2. Korean Food, Inc.

    FDA inspected Korean Food, Inc.'s Texas sprout and kimchi facility and found Listeria monitoring gaps, insanitary conditions, and misbranded kimchi labels.

    High risk
  3. Spectrum Medical Ltd

    Spectrum Medical marketed Quantum perfusion devices beyond cleared uses and had corrective-action failures.

    High risk
  4. P.T. Sankei Medical Industries

    FDA warned P.T. Sankei Medical Industries over unapproved changes to its single-use sphygmomanometer and quality system violations.

    High risk
  5. Future Diagnostics Solutions B.V.

    FDA cites Future Diagnostics over quality-system and reporting failures for STAT IntraOperative Intact PTH immunoassay kits.

    High risk
  6. Cardinal Health

    Cardinal Health marketed convenience kits with unapproved syringes and lacked supplier qualification for infusion-pump-compatible Monoject syringes.

    High risk
  7. Royal Philips

    FDA warns Royal Philips over unvalidated supplier molding for CT monitor cable and unreported device corrections at Suzhou plant.

    High risk
  8. C&T Dream Co., Ltd.

    C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.

    High risk
  9. Lipari Foods Operating Company, LLC

    Lipari Foods subsidiary JLM Manufacturing recalled walnut, hazelnut, and cashew products because labels did not declare major allergens.

    High risk
  10. Natco Pharma Limited

    FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.

    High risk
  11. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  12. Euro USA Inc

    Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.

    High risk
  13. Appleton City Feed Service LLC

    FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.

    High risk
  14. Jiangsu Meifan Biotechnology Co. Ltd.

    FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.

    High risk
  15. FirstCham Co., Ltd.

    FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.

    High risk
  16. Kilitch Healthcare India Limited

    FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.

    High risk
  17. Antaria Pty. Ltd.

    FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.

    High risk
  18. Thuan Thien Producing Trading Limited Company

    FDA warns Thuan Thien that its frozen juices lack validated 5-log pathogen reduction and coconut juice treatment is inadequate.

    High risk
  19. Bodywell Natural Skin Care Inc.

    FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.

    High risk
  20. Betone S.A. de C.V.

    FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.

    High risk
  21. Beckman Coulter Inc.

    FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.

    High risk
  22. Living Tree Community Foods, Inc.

    FDA warns Living Tree Community Foods that its RTE nut and seed butters had uncontrolled pathogen/allergen hazards and drug claims.

    High risk
  23. Deqing Jiarou Daily Chemical Co., Ltd.

    Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.

    High risk
  24. F1 Foods Inc. D/B/A Flavor First Foods Inc.

    F1 Foods Inc. d/b/a Flavor First Foods was cited for insanitary conditions and food-safety control failures at its ready-to-eat foods facility.

    High risk
  25. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  26. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  27. Jiangsu Shenli Medical Production Co., Ltd.

    FDA says Jiangsu Shenli marketed many piston syringes in the U.S. without required clearance or approval.

    High risk
  28. Medline Industries, LP

    FDA warns Medline over uncleared syringes in surgical kits and unresolved design and complaint failures.

    High risk
  29. Furst-McNess Company

    Furst-McNess's Lodi, Wisconsin feed mill made goat feed with toxic levels of monensin, sickening and killing goats.

    High risk
  30. Sen Up Huat Seafood Trading Sdn Bhd

    FDA warns Malaysian seafood processor Sen Up Huat over inadequate histamine controls in its seafood safety plan for bonito and other fish.

    High risk
  31. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  32. Exactech, Inc.

    Exactech shoulder and hip implants had quality-system and medical-device reporting failures, including a late GXL liner wear report.

    High risk
  33. Cosmetic Specialty Labs, Inc.

    FDA warned Cosmetic Specialty Labs after an inspection found manufacturing failures in OTC drugs and an unlisted product.

    High risk
  34. Thai Nakorn Patana Co., Ltd.

    FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.

    High risk
  35. Bell International Laboratories, Inc.

    Bell International Laboratories, an OTC drugmaker, was cited for manufacturing rule violations including missing glycerin DEG/EG testing and inadequate quality oversight.

    High risk
  36. Barsotti Juice Company, Inc.

    FDA warned Barsotti Juice that its organic carrot juice safety plan does not control Clostridium botulinum.

    High risk
  37. Knickerbocker 365, Inc.

    Knickerbocker 365 recalled hamburger buns that contained undeclared milk, and FDA found no allergen labeling controls at packaging.

    High risk
  38. Agila Corporation dba Woody’s Pet Food Deli

    FDA found Salmonella and Listeria in Woody's raw pet food and an unapproved additive in use.

    High risk
  39. Colgin, Inc.

    FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.

    High risk
  40. Fresenius Kabi AG

    FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.

    High risk
  41. Trang Thuy Seafood Co., LTD

    FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.

    High risk
  42. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  43. LightEyez Limited

    LightEyez eye drops sold in the U.S. were contaminated with microbes, and FDA cited unapproved new drug claims for its eye drops.

    High risk
  44. Amman Pharmaceutical Industries

    FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.

    High risk
  45. EzriCare LLC

    EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.

    High risk
  46. Delsam Pharma LLC

    Delsam Pharma distributed non-sterile, contaminated artificial tears and eye ointment made by its contract manufacturer, FDA found.

    High risk
  47. Empacadora Bilbo S.A. DBA Bilbosa

    FDA warns Ecuadorian seafood processor Bilbosa over seafood safety plan gaps for histamine and C. botulinum.

    High risk
  48. Sichuan Deebio Pharmaceutical Co. Ltd.

    FDA warns Sichuan Deebio Pharmaceutical over API manufacturing and data-integrity failures.

    High risk
  49. Pt Dua Kelinci

    FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.

    High risk
  50. US Chem Labs

    FDA warned US Chem Labs that it sells unapproved and misbranded Semaglutide, Tirzepatide, and Thymalin drugs online.

    High risk